ABBV (abbvie.com) יחס שווי שוק לשווי בספרים

Strict FDA standards and patent protection guarantee the reliability of AbbVie Inc. (ABBV). The company's market-to-book ratio on this GURU.Markets chart confirms this, with the indicator settling at -85.90. A strong R&D pipeline and immunology experts ensure resilience, while strategic marketing focused on extending drug patents creates a foundation for stable profit growth.

This indicator determines the market-to-book ratio, reflecting the premium or discount of assets relative to their book value. By analyzing changes in the price-to-book multiple, an investor assesses the margin of safety for AbbVie Inc., where stable demand for innovative therapeutic lines and an expanding patient base minimize the risk of asset impairment during market downturns.